CVS Strikes $20M Settlement To End SEC Probe
CVS Caremark Corp. has reached a $20 million settlement with the U.S. Securities and Exchange Commission to end an investigation into an accounting adjustment for its 2008 acquisition of Longs Drug...To view the full article, register now.
Already a subscriber? Click here to view full article